American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines.
American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines.
复制标题
DOI：
10.1161/circoutcomes.120.006967
复制
发表时间：
2020-08
期刊：
影响因子：
--
通讯作者：
de Lemos JA
中科院分区：
文献类型：
--
作者：
Alger HM;Rutan C;Williams JH 4th;Walchok JG;Bolles M;Hall JL;Bradley SM;Elkind MSV;Rodriguez F;Wang TY;Morrow DA;Das SR;de Lemos JA
为应对COVID-19大流行引发的公共卫生紧急情况，美国心脏协会志愿者和工作人员旨在为医疗和研究界快速开发和启动资源，通过共享学习、质量改进和研究加快科学进步。在2020年4月3日首次宣布后不到4周内，AHA的COVID-19 CVD登记系统由Get With The Guidelines®（GWTG）提供支持，收到了第一份临床记录。参与医院正在招募连续住院的活动性COVID-19疾病患者，无论CVD状态如何。该医院质量改进计划将允许参与的医院和卫生系统评估患者层面的数据，包括死亡率、重症监护病房（ICU）床位天数和呼吸机天数，这些数据来自对连续感染活动性COVID-19的成年患者的电子病历的单独审查。参与站点可以利用这些数据进行现场快速质量改进，并与其他机构进行比较。9周后，已有130多个站点加入该计划，并在国家数据集中提取了4，000多条记录。此外，聚合数据集将成为医学研究界的宝贵数据资源。AHA COVID-19 CVD登记将有助于更好地了解COVID-19对心血管疾病的影响，并将为COVID-19患者的评估和管理提供最佳实践。
In response to the public health emergency created by the COVID-19 pandemic, American Heart Association volunteers and staff aimed to rapidly develop and launch a resource for the medical and research community to expedite scientific advancement through shared learning, quality improvement, and research. In less than 4 weeks after it was first announced on April 3, 2020, AHA’s COVID-19 CVD Registry powered by Get With The Guidelines® (GWTG) received its first clinical records. Participating hospitals are enrolling consecutive hospitalized patients with active COVID-19 disease, regardless of CVD status. This hospital quality improvement program will allow participating hospitals and health systems to evaluate patient-level data including mortality rates, intensive care unit (ICU) bed days, and ventilator days from individual review of electronic medical records of sequential adult patients with active COVID-19 infection. Participating sites can leverage these data for onsite, rapid quality improvement and benchmarking versus other institutions. After 9 weeks, more than 130 sites have enrolled in the program and more than 4,000 records have been abstracted in the national dataset. Additionally, the aggregate dataset will be a valuable data resource for the medical research community. The AHA COVID-19 CVD Registry will support greater understanding of the impact of COVID-19 on cardiovascular disease and will inform best practices for evaluation and management of patients with COVID-19.